Cargando…
1227. Plazomicin Susceptibility Testing using ETEST(®) MIC for Enterobacterales
BACKGROUND: Plazomicin (PLZ) approved by FDA in June of 2018, is an aminoglycoside class antibacterial indicated for the treatment of adults with complicated urinary tract infections (cUTI) including pyelonephritis caused by Enterobacterales. It is used in patients who have limited or no alternative...
Autores principales: | Ying, Yun, Armstrong, Tom, Blanchard, Laurine, Kresken, Michael, Zambardi, Gilles, Pompilio, Marion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776453/ http://dx.doi.org/10.1093/ofid/ofaa439.1412 |
Ejemplares similares
-
Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales
por: Blanchard, Laurine S., et al.
Publicado: (2022) -
1222. Fosfomycin Susceptibility Testing using the new ETEST(®)FO
por: Halimi, Diane, et al.
Publicado: (2020) -
Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci
por: Blanchard, Laurine S., et al.
Publicado: (2023) -
656. Sulbactam-Durlobactam MIC Determination: Comparative Evaluation of the New ETEST(®) SUD to the CLSI 2021 Broth Microdilution Method
por: Sauvonnet, Veronique, et al.
Publicado: (2021) -
644. Comparative Evaluation of ETEST® ERV bioMérieux with the CLSI Broth Microdilution Method for Eravacycline MIC Determination
por: Sauvonnet, Veronique, et al.
Publicado: (2019)